BioAge Labs (BIOA) Current Leases (2023 - 2026)

BioAge Labs (BIOA) reported Current Leases of $646000.0 for Q1 2026, down 7.71% on a YoY basis from $700000.0 in Q1 2025, and up 11.0% sequentially from $582000.0 in Q4 2025.

BioAge Labs (BIOA) Current Leases (2023 - 2026) Analysis & Trends

BioAge Labs (BIOA) has 4 years of Current Leases data on file, last reported at $646000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases fell 7.71% year-over-year to $646000.0; the trailing twelve-month figure through Mar 2026 stood at $646000.0 (down 7.71% YoY), and the FY2025 full-year result was $582000.0, up 188.12% from the prior year.
  • Current Leases rose to $646000.0 in Q1 2026, from $582000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $700000.0 in Q1 2025 to a low of $194000.0 in Q4 2023.
  • A 4-year average of $475875.0 and a median of $581000.0 in 2025 frame the typical range for Current Leases.
  • Across the five-year window, Current Leases jumped 188.12% in 2025 and fell 7.71% in 2026, its largest moves.
  • Tracing BIOA's Current Leases over 4 years: stood at $194000.0 in 2023, then climbed by 4.12% to $202000.0 in 2024, then jumped by 188.12% to $582000.0 in 2025, then increased by 11.0% to $646000.0 in 2026.
  • Business Quant data shows BIOA's Current Leases at $646000.0 in Q1 2026, $582000.0 in Q4 2025, and $580000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -
6 RedHill Biopharma 21.32 Bn 21.32 Bn - 170,000.00
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn -
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -
10 BioAge Labs 921.83 Mn 921.83 Mn -10.37 Mn 646,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 646,000.00
Dec 31, 2025 582,000.00
Sep 30, 2025 580,000.00
Jun 30, 2025 630,000.00
Mar 31, 2025 700,000.00
Dec 31, 2024 202,000.00
Sep 30, 2024 273,000.00
Dec 31, 2023 194,000.00